Breaking News Instant updates and real-time market news.

ESPR

Esperion

$51.58

-2.52 (-4.66%)

08:48
12/10/18
12/10
08:48
12/10/18
08:48

Esperion price target raised to $104 from $89 at Stifel

Stifel analyst Derek Archila said his recent checks with key opinion leader doctors and PBMs has made him even more comfortable with the commercial opportunity for bempedoic acid in light of the recent price cuts on PCSK9s. His analysis suggests the BPA combo will be in-line with PCSK9s on a cost per Quality Adjusted of Life Year basis at the latter's lower price points. However, he thinks the combo's value proposition could be more compelling if BPA achieves or exceeds its 14% MACE reduction target in its CVOT trial. Archila raised his price target on Esperion shares to $104 from $89 and keeps a Buy rating on the stock.

ESPR Esperion
$51.58

-2.52 (-4.66%)

10/29/18
JMPS
10/29/18
NO CHANGE
Target $153
JMPS
Outperform
JMP reiterates $153 price target on Esperion following conference call
overall for the bempedoic acid Phase 3 program, JMP Securities analyst Jason Butler tells investors in a research note. He reiterates an Outperform rating on the shares with a $153 price target. The stock in afternoon trading is down 76c to $41.12. Management reiterated key takeaways from the Study 2 results, including the "clean safety profile and robust LDL-c lowering efficacy," especially in statin intolerant patients, with favorable MACE trends, says Butler. He continues to believe the LDL-C and hsCRP reductions, and optimized trial design, support a high probability that bempedoic acid will show a "robust and clinically important" cardiovascular risk reduction in the Clear outcomes trial. Bempedoic acid has a "clear commercial opportunity" as an oral therapy to address the millions of patients who remain inadequately controlled with elevated LDL-C despite currently available treatment options, Butler contends.
10/29/18
10/29/18
UPGRADE
Target $65

Outperform
Esperion upgraded to Outperform at Northland
As previously reported, Northland upgraded Esperion to Outperform from Market Perform with a $65 price target. Analyst Carl Byrnes said the positive TRL of Study 2 of '047 clearly supports BA's efficacy in lowering LDL-C, and should ease safety concerns arising from the May TLR study 1.
10/29/18
NORL
10/29/18
UPGRADE
NORL
Outperform
Esperion upgraded to Outperform from Market Perform at Northland
10/16/18
BTIG
10/16/18
INITIATION
Target $82
BTIG
Buy
Esperion initiated with a Buy at BTIG
BTIG analyst Thomas Shrader initiated Esperion (ESPR) with a Buy rating and a price target of $82, saying that with its development of bempedoic acid, or BA, to reduce cholesterol, the next key question is about the drug's safety. The analyst notes that while the data from Study 1 in May were disappointing, Study 2 readout in the next few weeks should have more answers. Shrader adds that the introduction of "non-stain" into the cholesterol market has already worked for Merck's (MRK) Zetia, and if BA is perceived well on its safety profile, it is "highly supportive" of its investment story.

TODAY'S FREE FLY STORIES

BOX

Box

$15.82

-0.38 (-2.35%)

, CARS

Cars.com

$12.56

0.48 (3.97%)

16:22
11/14/19
11/14
16:22
11/14/19
16:22
Hot Stocks
Starboard adds 7M shares of Box in Q3, exits Cars.com and Dollar Tree »

Jeffrey Smith's…

BOX

Box

$15.82

-0.38 (-2.35%)

CARS

Cars.com

$12.56

0.48 (3.97%)

DLTR

Dollar Tree

$108.71

0.305 (0.28%)

MRVL

Marvell

$26.98

-1.13 (-4.02%)

NTUS

Natus Medical

$31.54

-0.56 (-1.74%)

KAR

KAR Auction

$22.80

0.88 (4.01%)

NLOK

NortonLifeLock

$24.52

-0.05 (-0.20%)

ACM

Aecom

$43.49

1.275 (3.02%)

CERN

Cerner

$67.03

0.25 (0.37%)

PRGO

Perrigo

$48.03

-0.385 (-0.80%)

AAP

Advance Auto Parts

$156.93

-1.52 (-0.96%)

RPM

RPM

$74.62

0.915 (1.24%)

EBAY

eBay

$34.95

0.3 (0.87%)

SCOR

comScore

$3.98

(0.00%)

IWN

iShares Russell 2000 Value Index

$124.16

-0.03 (-0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 26

    Nov

  • 03

    Dec

  • 04

    Dec

  • 09

    Dec

  • 06

    Jan

NVDA

Nvidia

$209.88

1.33 (0.64%)

16:22
11/14/19
11/14
16:22
11/14/19
16:22
Hot Stocks
Nvidia to return to stock buybacks after closing Mellanox deal in early FY20 »

The company states:…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 20

    Nov

  • 06

    Jan

NVDA

Nvidia

$209.88

1.33 (0.64%)

16:21
11/14/19
11/14
16:21
11/14/19
16:21
Hot Stocks
Nvidia CEO says gaming business and hyperscale demand powered Q3 results »

CEO Jensen Huang says:…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 20

    Nov

  • 06

    Jan

UVE

Universal Insurance

$30.07

-0.43 (-1.41%)

16:21
11/14/19
11/14
16:21
11/14/19
16:21
Hot Stocks
Universal Insurance declares regular, special cash dividend »

Universal Insurance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APRE

Aprea Therapeutics

$26.92

2.45 (10.01%)

16:20
11/14/19
11/14
16:20
11/14/19
16:20
Earnings
Aprea Therapeutics reports Q3 EPS ($5.29), consensus ($3.94) »

As of September 30, prior…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVDA

Nvidia

$209.88

1.33 (0.64%)

16:20
11/14/19
11/14
16:20
11/14/19
16:20
Earnings
Nvidia reports Q3 adjusted EPS $1.78, consensus $1.57 »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 20

    Nov

  • 06

    Jan

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

16:20
11/14/19
11/14
16:20
11/14/19
16:20
Options
Closing CBOE SPX and VIX Index summary for November 14th »

The CBOE Volatility Index…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RH

RH

$175.21

2 (1.15%)

16:19
11/14/19
11/14
16:19
11/14/19
16:19
Hot Stocks
Breaking Hot Stocks news story on RH »

RH up 7% in afterhours…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DLB

Dolby

$65.56

-0.14 (-0.21%)

16:19
11/14/19
11/14
16:19
11/14/19
16:19
Earnings
Dolby sees FY20 adjusted EPS $3.40-$3.50, consensus $2.87 »

Sees FY20 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 03

    Dec

  • 04

    Dec

  • 05

    Dec

  • 12

    Dec

  • 13

    Dec

CSSE

Chicken Soup for the Soul

$9.99

0.28 (2.88%)

16:19
11/14/19
11/14
16:19
11/14/19
16:19
Earnings
Chicken Soup for the Soul reports Q3 adjusted EPS ($1.03), consensus (5c) »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

DLB

Dolby

$65.56

-0.14 (-0.21%)

16:17
11/14/19
11/14
16:17
11/14/19
16:17
Earnings
Dolby sees Q1 adjusted EPS 45c-51c, consensus 65c »

Sees Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 03

    Dec

  • 04

    Dec

  • 05

    Dec

  • 12

    Dec

  • 13

    Dec

CY

Cypress Semiconductor

$23.43

0.01 (0.04%)

16:17
11/14/19
11/14
16:17
11/14/19
16:17
Downgrade
Cypress Semiconductor rating change  »

Cypress Semiconductor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NKE

Nike

$91.26

-0.02 (-0.02%)

16:17
11/14/19
11/14
16:17
11/14/19
16:17
Hot Stocks
Nike raises quarterly dividend to 24.5c from 22c per share »

The dividend declared…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLOB

Globant

$109.21

4.195 (3.99%)

16:17
11/14/19
11/14
16:17
11/14/19
16:17
Earnings
Globant raises FY19 non-IFRS EPS view to $2.23-$2.27 from $2.19-$2.25 »

Consensus $2.24. Narrows…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

16:17
11/14/19
11/14
16:17
11/14/19
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLSN

Celsion

$1.38

0.29 (26.73%)

16:16
11/14/19
11/14
16:16
11/14/19
16:16
Earnings
Celsion reports Q3 EPS (25c), consensus (28c) »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

HAYN

Haynes

$35.83

-0.31 (-0.86%)

16:16
11/14/19
11/14
16:16
11/14/19
16:16
Earnings
Haynes reports Q4 EPS 48c, consensus 40c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 19

    Nov

DLB

Dolby

$65.56

-0.14 (-0.21%)

16:16
11/14/19
11/14
16:16
11/14/19
16:16
Earnings
Dolby reports Q4 adjusted EPS 66c, consensus 48c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 03

    Dec

  • 04

    Dec

  • 05

    Dec

  • 12

    Dec

  • 13

    Dec

GLOB

Globant

$109.21

4.195 (3.99%)

16:16
11/14/19
11/14
16:16
11/14/19
16:16
Earnings
Globant sees Q4 non-IFRS adjusted EPS 58c-62c, consensus 63c »

Sees Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

GIFI

Gulf Island Fabrication

$4.38

0.07 (1.62%)

16:16
11/14/19
11/14
16:16
11/14/19
16:16
Hot Stocks
Gulf Island Fabrication board Chairman Jack Laborde to step down »

Gulf Island Fabrication…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLOB

Globant

$109.21

4.195 (3.99%)

16:16
11/14/19
11/14
16:16
11/14/19
16:16
Earnings
Globant reports Q3 non-IFRS EPS 62c, consensus 59c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

$NYE

NYSE Market Internals

$0.00

(0.00%)

16:16
11/14/19
11/14
16:16
11/14/19
16:16
Technical Analysis
NYSE market internals summary »

Volume was below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RH

RH

$175.21

2 (1.15%)

, BRK.A

Berkshire Hathaway

$329,095.00

-505 (-0.15%)

16:15
11/14/19
11/14
16:15
11/14/19
16:15
Hot Stocks
Warren Buffet's Berkshire Hathaway takes stake in RH »

The stake in RH was…

RH

RH

$175.21

2 (1.15%)

BRK.A

Berkshire Hathaway

$329,095.00

-505 (-0.15%)

BRK.B

Berkshire Hathaway

$219.42

-0.39 (-0.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:15
11/14/19
11/14
16:15
11/14/19
16:15
General news
Breaking General news story  »

Week of 11/4 Money Supply…

16:15
11/14/19
11/14
16:15
11/14/19
16:15
General news
Breaking General news story  »

Week of 11/13 Fed Balance…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.